Development of DNA Aptamer-Based PROTACs That Degrade the Estrogen Receptor
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of DNA Aptamer-Based PROTACs That Degrade the Estrogen Receptor
Authors
Keywords
-
Journal
ACS Medicinal Chemistry Letters
Volume 14, Issue 6, Pages 827-832
Publisher
American Chemical Society (ACS)
Online
2023-05-20
DOI
10.1021/acsmedchemlett.3c00126
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inducible Degradation of Oncogenic Nucleolin Using an Aptamer-Based PROTAC
- (2023) Miao Chen et al. Journal of Medicinal Chemistry
- Selective degradation of the p53‐R175H oncogenic hotspot mutant by an RNA aptamer‐based PROTAC
- (2023) Lingping Kong et al. Clinical and Translational Medicine
- Phase 1/2 study of ARV-110, an androgen receptor (AR) PROTAC degrader, in metastatic castration-resistant prostate cancer (mCRPC).
- (2022) Xin Gao et al. JOURNAL OF CLINICAL ONCOLOGY
- PROTAC targeted protein degraders: the past is prologue
- (2022) Miklós Békés et al. NATURE REVIEWS DRUG DISCOVERY
- Non-small molecule PROTACs (NSM-PROTACs): Protein degradation kaleidoscope
- (2022) Sinan Ma et al. Acta Pharmaceutica Sinica B
- ARV-471, an estrogen receptor (ER) PROTACdegrader, combined with palbociclib in advanced ER+/human epidermal growth factor receptor 2–negative (HER2-) breast cancer: Phase 1b cohort (part C) of a phase 1/2 study.
- (2022) Erika P. Hamilton et al. JOURNAL OF CLINICAL ONCOLOGY
- Nucleic-Acid-Based Targeted Degradation in Drug Discovery
- (2022) Wei Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Insights into the binding mode of AS1411 aptamer to nucleolin
- (2022) Lihua Bie et al. Frontiers in Molecular Biosciences
- Development of a novel PROTAC using the nucleic acid aptamer as a targeting ligand for tumor selective degradation of nucleolin
- (2022) Lin Zhang et al. Molecular Therapy-Nucleic Acids
- Aptamer‐PROTAC Conjugates (APCs) for Tumor‐Specific Targeting in Breast Cancer
- (2021) Shipeng He et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- TF-PROTACs Enable Targeted Degradation of Transcription Factors
- (2021) Jing Liu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Destruction of DNA‐Binding Proteins by Programmable Oligonucleotide PROTAC (O'PROTAC): Effective Targeting of LEF1 and ERG
- (2021) Jingwei Shao et al. Advanced Science
- Systematic Evolution of Ligands by Exponential Enrichment Technologies and Aptamer-Based Applications: Recent Progress and Challenges in Precision Medicine of Infectious Diseases
- (2021) Yixin Xu et al. Frontiers in Bioengineering and Biotechnology
- Development of Chimeric Molecules That Degrade the Estrogen Receptor Using Decoy Oligonucleotide Ligands
- (2021) Miyako Naganuma et al. ACS Medicinal Chemistry Letters
- Recent Progress in Aptamer Discoveries and Modifications for Therapeutic Applications
- (2020) Shuaijian Ni et al. ACS Applied Materials & Interfaces
- A PROTAC peptide induces durable β-catenin degradation and suppresses Wnt-dependent intestinal cancer
- (2020) Hongwei Liao et al. Cell Discovery
- SELEX-based DNA Aptamer Selection: A Perspective from the Advancement of Separation Techniques
- (2020) Shingo SAITO ANALYTICAL SCIENCES
- Proteolysis targeting chimera (PROTAC) in drug discovery paradigm: Recent progress and future challenges
- (2020) Shenxin Zeng et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- First targeted protein degrader hits the clinic
- (2019) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Recent Advances in Aptamer Discovery and Applications
- (2019) Yang Zhang et al. MOLECULES
- Aptamer-based Targeted Delivery of a G-quadruplex Ligand in Cervical Cancer Cells
- (2019) Josué Carvalho et al. Scientific Reports
- Therapeutic applications of AS1411 aptamer, an update review
- (2019) Rezvan Yazdian-Robati et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Aptamer chemistry
- (2018) Pascal Röthlisberger et al. ADVANCED DRUG DELIVERY REVIEWS
- Derivatization of inhibitor of apoptosis protein (IAP) ligands yields improved inducers of estrogen receptor α degradation
- (2018) Nobumichi Ohoka et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine
- (2017) Zhenjian Zhuo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- In VivoKnockdown of Pathogenic Proteins via Specific and Nongenetic Inhibitor of Apoptosis Protein (IAP)-dependent Protein Erasers (SNIPERs)
- (2017) Nobumichi Ohoka et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- DNA aptamer probes for detection of estrogen receptor α positive carcinomas
- (2017) Arghya Sett et al. Translational Research
- Posttranslational protein knockdown coupled to receptor tyrosine kinase activation with phosphoPROTACs
- (2013) J. Hines et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of RNA Aptamer Specific to Mutant KRAS Protein
- (2010) Sujin Jeong et al. OLIGONUCLEOTIDES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started